Intraprostatic injection of tranexamic acid to control refractory bleeding while maintaining therapeutic anticoagulation

Tranexamic acid (TXA) has been used to manage menstrual bleeding and reduce bleeding during orthopedic procedures, but has not been widely used in urology. We present a patient with refractory gross hematuria with required therapeutic anticoagulation who failed multiple other measures to control pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Brian, Knoedler, Margaret, Roberge, Gray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Functional Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818137/
https://www.ncbi.nlm.nih.gov/pubmed/31681534
http://dx.doi.org/10.1016/j.eucr.2019.100914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818137/
https://www.ncbi.nlm.nih.gov/pubmed/31681534
http://dx.doi.org/10.1016/j.eucr.2019.100914

Ejemplares similares